AWM
GILD icon

Argent Wealth Management’s Gilead Sciences GILD Stock Holding History

Argent Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$242K Buy
3,556
+77
+2% +$5.9K 0.04% 151
2020
Q1 		$270K Buy
3,479
+235
+7% +$16.2K 0.05% 137
2019
Q4 		$211K Buy
+3,244
New +$211K 0.04% 170

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Argent Wealth Management's GILD Position: Q2 2020 in Review

Argent Wealth Management increased its Gilead Sciences (GILD) stake by 2.2% in Q2 2020, buying an estimated $5.9K and bringing the position to 3,556 shares worth $242K. The position accounts for 0.04% of the portfolio, ranked #151.

Argent Wealth Management first reported a position in GILD in Q4 2019 and has held it in 3 quarters since. The position peaked at $270K in Q1 2020. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Argent Wealth Management held 3,556 shares of Gilead Sciences worth $242K as of Q2 2020.
  • Argent Wealth Management bought 77 Gilead Sciences shares in Q2 2020, an estimated $5.9K.
  • Gilead Sciences made up 0.04% of Argent Wealth Management's portfolio in Q2 2020, its #151 holding.
  • Argent Wealth Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 3 quarters since.
  • Argent Wealth Management's Gilead Sciences position peaked at $270K in Q1 2020.
  • 1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Argent Wealth Management's 13F filing for Q2 2020, filed 17 Aug 2020.